Enterome is a Paris-based private company with advanced technology and products in the emerging field of disease management of the human gut microbiome. Enterome has recently opened a subsidiary in Cambridge (MA). Our company has been established in 2012 and has already raised a €32m in three rounds with private equity funds (Seventure, Omnes Capital, Lundbeckfond Ventures, Health for Life Capital) and strategic investors (INRA Transfert, Shire & Nestlé).
Type
Private
HQ
Paris, FR
Founded
2011
Size (employees)
45 (est)+3%
ENTEROME Bioscience was founded in 2011 and is headquartered in Paris, FR
Report incorrect company information

Key People/Management at ENTEROME Bioscience

Pierre Belichard

Pierre Belichard

CEO
Marie-Laure Bouttier

Marie-Laure Bouttier

COO
Rodolphe Clerval

Rodolphe Clerval

CBO
Karima Taquil Adamo

Karima Taquil Adamo

Head of Clinical Development
Alessandra CERVINO

Alessandra CERVINO

Head of Discovery

ENTEROME Bioscience Office Locations

ENTEROME Bioscience has offices in Cambridge, Évry and Paris
Paris, FR (HQ)
96 Avenue Ledru-Rollin
Évry, FR
5 Rue Henri Auguste Desbruères
Cambridge, US
One Broadway 1 Broadway
Cambridge, US
1 Broadway
Show all (4)
Report incorrect company information

ENTEROME Bioscience Financials and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$123.5 m

Latest funding size

$38.50 m

Time since last funding

4 months ago

Investors

ENTEROME Bioscience's latest funding round in January 2018 was reported to be $38.5 m. In total, ENTEROME Bioscience has raised $123.5 m
Report incorrect company information